My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$TE {{ '2015-07-30T19:01:27+0000' | timeago}} • Webcast

$TE 2Q15 Q&A: Daniel of Credit Suisse asked about IRP for New Mexico. John says the IRP filing is next spring that not refers April or March, but in the next spring time period. Our teams are working towards that. The original owners were spending about $30MM a year in capital.

User Ramesh Raju {{ '2017-01-24T08:15:35+0000' | timeago}}

For the combined company, CEO of Altimmune, Bill Enright and CFO of Altimmune, Elizabeth Czerepak, will continue to serve in their respective positions.

User Ramesh Raju {{ '2017-01-24T08:11:25+0000' | timeago}}

Upon completion of the transaction the combined company will trade under the new ticker symbol "ALT." The new company will be based in Gaithersburg, Maryland.

User Ramesh Raju {{ '2017-01-24T07:57:37+0000' | timeago}}

Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

$DD {{ '2017-01-24T11:37:21+0000' | timeago}} • Announcement

$DD expects the merger with $DOW to close in 1H17. For 1Q17, $DD expects GAAP earnings to decrease about 18% from last year. The company's GAAP earnings include an expected charge of about $0.15 per share for transaction costs associated with the planned merger with $DOW.

$DD {{ '2017-01-24T11:34:22+0000' | timeago}} • Announcement

$DD's sales for 4Q16 declined 2% YoverY, as a 1% benefit from currency was offset by a 2% decrease in local price and 1% decline in volume. Volume declined as growth in Performance Materials, Electronics & Communications and Industrial Biosciences was more than offset by declines in Agriculture, on timing of 4Q seed sales.

$DD {{ '2017-01-24T11:33:53+0000' | timeago}} • Announcement

$DD swung to a 4Q16 profit from a loss last year, driven by lower expenses despite a decline in sales. Net income was $263MM or $0.30 per share compared to a loss of $256MM or $0.29 per share last year. Net sales fell to $5.21Bil from $5.3Bil. Non-GAAP EPS increased to $0.51 from $0.27.

$PNFP {{ '2017-01-24T11:31:32+0000' | timeago}} • Announcement

$PNFP announced a proposed underwritten public offering of common shares to raise aggregate gross proceeds of $175MM. $PNFP plans to use proceeds to pay related fees and expenses; provide capital support for the growth of Pinnacle Bank, including in connection with its proposed acquisition of BNC Bancorp; and for other general corporate purposes.

$JCP {{ '2017-01-24T11:25:45+0000' | timeago}} • Announcement

$JCP extended its existing stockholder rights plan for an additional three years to continue protecting the company's valuable net operating loss carryforwards (NOLs). As of the end of FY15, the company had about $2.6Bil in NOLs, which in certain circumstances to offset future taxable income and reduce federal income tax liability.